Serum C-peptide levels and risk of death among adults without diabetes mellitus

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 9, 2013, Pages

  Min, Jin Young ^a   Min, Kyoung Bok ^b  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; UNITED STATES;

EID: 84878890231     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.121950     Document Type: Article

References (27)

1. Horwitz DL, Kuzuya H, Rubenstein AH. Circulating serum C-peptide: a brief review of diagnostic implications. N Engl J Med 1976;295:207-9.
2. Clark PM, Hales CN. How to measure plasma insulin. Diabetes Metab Rev 1994;10:79-90. (Pubitemid 24252908)
3. Webb PG, Bonser AM. Basal C-peptide in the discrimination of type I from type II diabetes. Diabetes Care 1981;4:616-9. (Pubitemid 12181464)
4. Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997;277:563-6. (Pubitemid 27369004)
5. Johansson BL, Sjöberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992;35:121-8.
6. Marx N, Walcher D, Raichle C, et al. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004;24:540-5. (Pubitemid 38326150)
7. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogeneous Chinese population with normal glucose tolerance. Int J Cardiol 1999;68:179-86. (Pubitemid 29083468)
8. Haban P, Simoncic R, Zidekova E, et al. Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome. Med Sci Monit 2002;8:CR175-9. (Pubitemid 34263048)
9. Chen CH, Tsai ST, Chuang JH, et al. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol 1995;76:585-8.
10. Kim ST, Kim BJ, Lim DM, et al. Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J 2011;35:41-9.
11. Patel N, Taveira TH, Choudhary G, et al. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc 2012;1:e003152.
12. Marx N, Silbernagel G, Brandenburg V, et al. C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC Study. Diabetes Care 2013;36:708-14.
13. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994;Jul:1-407.
14. Analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988-1994). Hyattsville (MD): National Center for Health Statistics, Centers for Disease Control and Prevention; 1996. Available: www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf (accessed 2013 Apr. 9).
15. National Center for Health Statistics. NHANES III Linked Mortality File. Hyattsville (MD): The Center; 2006.
16. Gunther EW, Lewis BL, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Atlanta (GA): US Department of Health and Human Services; 1996.
17. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;11:541-8.
18. Anderson RN, Miniño AM, Hoyert DL, et al. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001;49:1-32.
19. Hirai FE, Moss SE, Klein BE, et al. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 2008;31:493-7.
20. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
21. Silbernagel G, Grammer TB, Winkelmann BR, et al. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011;34:1355-61.
22. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998;21:360-7. (Pubitemid 28101069)
23. Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40. (Pubitemid 29056916)
24. Walcher D, Aleksic M, Jerg V, et al. C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004;53:1664-70. (Pubitemid 38857022)
25. Walcher D, Babiak C, Poletek P, et al. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 2006;99:1181-7. (Pubitemid 44808654)
26. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA 1990;263:2893-8. (Pubitemid 20173164)
27. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 2000;284:3157-9. (Pubitemid 32039079)